243 related articles for article (PubMed ID: 21858814)
1. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer.
Wang DS; Chen DL; Ren C; Wang ZQ; Qiu MZ; Luo HY; Zhang DS; Wang FH; Li YH; Xu RH
Int J Cancer; 2012 Jul; 131(2):461-8. PubMed ID: 21858814
[TBL] [Abstract][Full Text] [Related]
2. Association between hepatitis B virus and pancreatic cancer.
Hassan MM; Li D; El-Deeb AS; Wolff RA; Bondy ML; Davila M; Abbruzzese JL
J Clin Oncol; 2008 Oct; 26(28):4557-62. PubMed ID: 18824707
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus status and risk of pancreatic ductal adenocarcinoma: a case-control study from China.
Ben Q; Li Z; Liu C; Cai Q; Yuan Y; Wang K; Xiao L; Gao J; Zhang H
Pancreas; 2012 Apr; 41(3):435-40. PubMed ID: 22422136
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism.
Zhou Y; Zhou Q; Lin Q; Chen R; Gong Y; Liu Y; Yu M; Zeng B; Li K; Chen R; Li Z
Int J Cancer; 2013 Oct; 133(8):1867-75. PubMed ID: 23564396
[TBL] [Abstract][Full Text] [Related]
5. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a simple model for hepatitis B virus infection status based on trait marker from quantitative measurement of serum markers.
Ningyu Z; Ying Z; Hui L
J Med Virol; 2015 Jun; 87(6):1008-12. PubMed ID: 25716104
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and C viruses are not risks for pancreatic adenocarcinoma.
Chang MC; Chen CH; Liang JD; Tien YW; Hsu C; Wong JM; Chang YT
World J Gastroenterol; 2014 May; 20(17):5060-5. PubMed ID: 24803819
[TBL] [Abstract][Full Text] [Related]
8. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
[TBL] [Abstract][Full Text] [Related]
9. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
[TBL] [Abstract][Full Text] [Related]
10. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
11. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
Zhang M; Wu R; Jiang J; Minuk GY; Niu J
Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B prevalence among women in child-bearing age in Shandong Province, China, 2014].
Zhang L; Liu JY; Lyu JJ; Yan BY; Feng Y; Wu WL; Song LZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):475-479. PubMed ID: 28592088
[No Abstract] [Full Text] [Related]
13. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the presence of HBV-DNA in isolated anti-HBc positive cases and their importance in blood banking].
Bal SH; Heper Y; Kumaş LT; Mistik R; Töre O
Mikrobiyol Bul; 2009 Apr; 43(2):243-50. PubMed ID: 19621609
[TBL] [Abstract][Full Text] [Related]
15. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
16. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus e antigen and primary hepatocellular carcinoma.
Lin TM; Chen CJ; Lu SN; Chang AS; Chang YC; Hsu ST; Liu JY; Liaw YF; Chang WY
Anticancer Res; 1991; 11(6):2063-5. PubMed ID: 1663719
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B viral markers in patients with primary hepatocellular carcinoma in Taiwan.
Chien MC; Tong MJ; Lo KJ; Lee JK; Milich DR; Vyas GN; Murphy BL
J Natl Cancer Inst; 1981 Mar; 66(3):475-9. PubMed ID: 6162990
[TBL] [Abstract][Full Text] [Related]
20. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
Launay O; Masurel J; Servant-Delmas A; Basse-Guérineau AL; Méritet JF; Laperche S; Sogni P; Rosenberg AR
J Viral Hepat; 2011 Oct; 18(10):721-9. PubMed ID: 21914087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
